La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Humans »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Human Growth Hormone (blood) < Humans < Huntingtin Protein (genetics)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 1953.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
000025 (1999) W J HolsteinRewiring the brain. How a bright idea became an innovative medical device.
000026 (1999) A M Bonnet [France] ; J L HouetoPathophysiology of Parkinson's disease.
000027 (1999) P. Krack [France] ; P. Pollak ; P. Limousin ; A. Benazzouz ; G. Deuschl ; A L BenabidFrom off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity.
000028 (1999) O. Rascol [France] ; O. Blin ; C. Thalamas ; S. Descombes ; C. Soubrouillard ; P. Azulay ; N. Fabre ; F. Viallet ; K. Lafnitzegger ; S. Wright ; J H Carter ; J G NuttABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease.
000029 (1999) E C Hirsch [France]Mechanism and consequences of nerve cell death in Parkinson's disease.
000030 (1999) A. Elbaz [France] ; F. Grigoletto ; M. Baldereschi ; M M Breteler ; J M Manubens-Bertran ; S. Lopez-Pousa ; J F Dartigues ; A. Alpérovitch ; C. Tzourio ; W A RoccaFamilial aggregation of Parkinson's disease: a population-based case-control study in Europe. EUROPARKINSON Study Group.
000032 (1999) M P Muriel [France] ; V. Bernard ; A I Levey ; O. Laribi ; D N Abrous ; Yves Agid [France] ; B. Bloch ; E C HirschLevodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease.
000034 (1999) E C Hirsch [France] ; S. Hunot ; P. Damier ; B. Brugg ; B A Faucheux ; P P Michel ; M. Ruberg ; M P Muriel ; A. Mouatt-Prigent ; Yves Agid [France]Glial cell participation in the degeneration of dopaminergic neurons in Parkinson's disease.
000035 (1999) M. Vidailhet [France] ; S. Rivaud ; N. Gouider-Khouja ; B. Pillon ; B. Gaymard ; Yves Agid [France] ; C. Kennard ; C. Pierrot-DeseillignySaccades and antisaccades in parkinsonian syndromes.
000036 (1999) O. Rascol [France] ; C. Brefel-Courbon ; S. Descombes ; J L MontastrucClinical pharmacology of levodopa-induced dyskinesia in parkinsonian patients.
000037 (1999) P. Damier [France]New aspects in the pathophysiology of dyskinesia. Salpêtrière Deep Brain Stimulation Group.
000038 (1999) L J Defebvre [France] ; J L Blatt ; S C Blond ; J L Bourriez ; J D Guieu ; A. DestéeEffect of long-term stimulation of the ventral intermediate thalamic nucleus on gait in Parkinson's disease.
000039 (1999) M. Peschanski [France] ; G L Defer ; S. Dethy ; P M Hantraye ; M. Levivier ; J P Nguyen ; P. CesaroThe need for phase III studies in experimental surgical treatments of Parkinson's disease.
000040 (1999) M B Delisle [France] ; J R Murrell ; R. Richardson ; J A Trofatter ; O. Rascol ; X. Soulages ; M. Mohr ; P. Calvas ; B. GhettiA mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy.
000041 (1999) G. Serratrice [France] ; B. MichelPain in Parkinson's disease patients.
000042 (1999) C. Thalamas [France] ; A. Taylor ; C. Brefel-Courbon ; S. Eagle ; K. Fitzpatrick ; O. RascolLack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease.
000043 (1999) P. Damier [États-Unis] ; E C Hirsch ; Yves Agid [France] ; A M GraybielThe substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry.
000044 (1999) P. Damier [France] ; E C Hirsch ; Yves Agid [France] ; A M GraybielThe substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.
000045 (1999) G L Defer [France] ; H. Widner ; R M Marié ; P. Rémy ; M. LevivierCore assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD).
000046 (1999) L J Defebvre [France] ; P. Derambure ; J L Bourriez ; F. Cassim ; J D Guieu ; A. DestéeMotor programming is more affected in progressive supranuclear palsy than in Parkinson's disease: a spatiotemporal study of event-related desynchronization.
000047 (????) H. Bagheri [France] ; C. Damase-Michel ; M. Lapeyre-Mestre ; S. Cismondo ; D. O'Connell ; J M Senard ; O. Rascol ; J L MontastrucA study of salivary secretion in Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Humans" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Humans" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Humans
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024